Emphysema - Complete Explanation

1. What is COPD?

• Currently the 4th leading cause of death worldwide
• Emphysema and chronic bronchitis are the two major forms of COPD - they often coexist in the same patient because they share the same main cause: cigarette smoking
• COPD is an obstructive lung disease, meaning there is increased resistance to airflow - the FEV1/FVC ratio drops below 0.7

2. Definition of Emphysema

Irreversible (permanent) enlargement of airspaces distal to the terminal bronchiole, accompanied by destruction of their walls, without obvious fibrosis.

• Damage is beyond the terminal bronchiole (in the acini/alveoli)
• The walls are destroyed (not just stretched)
• There is no fibrosis - this distinguishes it from other lung conditions

3. Types of Emphysema

4. Pathogenesis

Main Causes

• Tobacco smoking (accounts for ~80% of COPD)
• α1-antitrypsin (α1-AT) deficiency (genetic cause)

Four Mechanisms

A. Toxic Injury and Inflammation

• Cigarette smoke damages respiratory epithelium
• Resident macrophages and epithelial cells release inflammatory mediators: leukotriene B4, IL-8, TNF
• These attract neutrophils from the circulation
• Neutrophils amplify inflammation and cause structural damage via growth factors and pro-inflammatory cytokines

B. Protease-Antiprotease Imbalance (Most Important)

• Nicotine acts as a chemoattractant for neutrophils
• Neutrophils release elastase (a protease) and reactive oxygen species (ROS)
• Elastase breaks down elastin - the elastic tissue that normally holds small airways open via radial traction during expiration
• Normally, α1-antitrypsin (produced by the liver) inhibits elastase
• In smokers or those with α1-AT deficiency: elastase exceeds inhibitor → elastic tissue destruction → airways collapse on expiration → airflow obstruction

C. Oxidative Stress

• Tobacco smoke and inflammatory cells produce oxidants (ROS) causing further tissue damage
• NRF2 is a transcription factor that normally activates antioxidant defense genes (including glutathione)
• Genetic variation in NRF2 is linked to increased susceptibility to smoking-related lung disease

D. Infection

• Does NOT initiate tissue destruction
• Superimposed bacterial/viral infections worsen existing inflammation and chronic bronchitis

5. Why Does Airflow Get Obstructed?

1. Loss of elastic tissue → loss of radial traction → small airways collapse during expiration
2. Goblet cell hyperplasia → excess mucus plugging airways
3. Inflammatory infiltrates in bronchial walls (neutrophils, macrophages, B cells, T cells)
4. Smooth muscle hypertrophy + peribronchial fibrosis → thickening of bronchiolar walls

6. α1-Antitrypsin Deficiency (Genetic Emphysema)

• Autosomal recessive disorder
• Encoded at the Pi locus on chromosome 14q
• Pi ZZ genotype (homozygous Z allele): serum α1-AT drops to <15% of normal
• ~1% of all emphysema patients have this defect

• 80% of Pi ZZ individuals develop panacinar emphysema - earlier in life and more severe if they smoke

• α1-AT is produced by hepatocytes, bone marrow cells, and lymphoid cells
• Also causes liver disease (protein accumulates in hepatocytes)

7. Morphology (What You See)

Gross (Naked Eye)

• Voluminous, enlarged lungs - often overlap and hide the heart
• Upper two-thirds more severely affected
• Blebs (<1 cm) and bullae (>1 cm) - large air-filled cysts, especially at the apex

Microscopic (Under the Microscope)

• Abnormally large alveoli separated by thin, destroyed septa
• Loss of alveolar attachments to small airway walls
• Pores of Kohn (inter-alveolar openings) become so large that septa appear to be "floating" in airspace
• Inflammatory changes around small airways

8. Clinical Features (Signs & Symptoms)

• Narrowed airways → can't fully exhale → residual air builds up → hyperinflation

9. Complications

• Pulmonary arterial hypertension - from chronic hypoxia causing prolonged vasoconstriction
• Cor pulmonale (right heart enlargement from pulmonary hypertension) → right-sided heart failure
• Pneumothorax - especially from rupture of bullae (particularly in paraseptal emphysema in young adults)

1. Coronary artery disease
2. Respiratory failure
3. Right-sided heart failure
4. Massive lung collapse (pneumothorax)

10. Diagnosis

11. Treatment

1. Smoking cessation - most important intervention
2. Oxygen therapy
3. Long-acting bronchodilators + inhaled corticosteroids
4. Chest physiotherapy
5. Surgical options:
   • Bullectomy (removal of bullae)
   • Lung volume reduction surgery
   • Lung transplantation
6. α1-AT replacement therapy - under evaluation for genetic cases

12. Other Special Forms

Quick Summary

Emphysema = permanent destruction of alveolar walls distal to terminal bronchioles → air trapping → hyperinflation → obstructive airflow pattern. Main causes are smoking (centriacinar type) and α1-AT deficiency (panacinar type). The core mechanism is elastase-antiprotease imbalance destroying lung elastic tissue. Complications include cor pulmonale, respiratory failure, and pneumothorax.

• Cigarette smoke recruits neutrophils, which release elastase
• α1-Antitrypsin (produced by the liver) keeps elastase in check
• Elastin is preserved, small airways stay open via radial traction, and expiration is normal

• Heavy smoking OR genetic α1-AT deficiency (Pi ZZ genotype, chromosome 14q) tips the balance
• Elastase overwhelms the available α1-AT
• Elastin in alveolar walls is digested and destroyed
• Without elastic support, small airways collapse during expiration
• Air traps in the lungs → hyperinflation → permanent alveolar wall destruction = Emphysema

1. Protease-Antiprotease Imbalance (Primary Mechanism)

• Cigarette smoke and noxious particles recruit neutrophils and macrophages into the lung
• These cells release proteases - mainly elastase and matrix metalloproteinases (MMPs)
• Elastase directly digests elastin, the structural protein that makes up the alveolar wall framework
• Normally, α1-antitrypsin neutralizes elastase - but in smokers or Pi ZZ individuals, elastase activity overwhelms the inhibitor
• Result: the connective tissue scaffold of alveolar walls is broken down and cannot be repaired

2. Oxidative Stress

• Tobacco smoke and activated inflammatory cells (neutrophils, macrophages) flood the lung with reactive oxygen species (ROS)
• ROS directly damage alveolar epithelial cells and endothelial cells
• ROS also inactivate α1-antitrypsin, making the protease-antiprotease imbalance even worse
• The antioxidant defense (controlled by NRF2) is overwhelmed in heavy smokers

3. Alveolar Cell Apoptosis (Programmed Cell Death)

• Oxidative stress and inflammatory mediators trigger apoptosis (cell death) of:
  • Type I pneumocytes (cover alveolar surface)
  • Type II pneumocytes (repair and surfactant-producing cells)
  • Capillary endothelial cells
• When these cells die faster than they can be replaced, the alveolar wall physically disintegrates
• This is a key reason why emphysematous damage is irreversible - the repair machinery is itself destroyed

4. Chronic Inflammation

• Persistent inflammatory cells in the alveolar walls release:
  • TNF-α, IL-8, leukotriene B4 - sustain neutrophil/macrophage recruitment
  • Growth factors that paradoxically cause structural remodeling rather than proper repair
• This chronic low-grade inflammation keeps the destructive cycle going even after smoking stops

The End Result

Gross Morphology (Naked Eye)

Overall Appearance

• Lungs are voluminous and over-inflated - they are larger and heavier than normal
• They overlap and hide the heart when the chest is opened (a classic finding)
• Lungs feel spongy and may not collapse normally when the chest is opened

Distribution

• Upper two-thirds of the lungs are more severely affected (especially in centriacinar/smoking-related emphysema)
• Panacinar (α1-AT deficiency) preferentially affects the lower lobes and bases

Surface Features

• Blebs - air-filled spaces less than 1 cm, just under the pleura (subpleural)
• Bullae - larger air-filled cysts greater than 1 cm, often at the apex
• Bullae are especially characteristic of:
  • Paraseptal (distal acinar) emphysema
  • Irregular emphysema secondary to scarring

Cut Surface

• Large, abnormally wide alveoli visible to the naked eye
• Thin, wispy alveolar walls between the enlarged spaces
• Loss of the normal fine sponge-like texture

Microscopic Morphology (Histology)

Alveolar Changes

• Abnormally enlarged alveoli - the defining feature
• Thinned and destroyed alveolar septa - walls are sparse and fragile
• Loss of alveolar attachments to the outer wall of small airways - the airways lose their structural support

Pores of Kohn

• The inter-alveolar pores (Pores of Kohn) become so enlarged that adjacent alveoli merge
• Septa appear to be "floating" freely in airspace, or protrude blindly into the lumen with a club-shaped end - a hallmark microscopic sign

Vascular Changes

• Reduced capillary bed in alveolar walls
• Thickening of pulmonary arterial walls in advanced disease (due to pulmonary hypertension)

Airway / Inflammatory Changes

• Inflammatory infiltrates in bronchial and bronchiolar walls:
  • Neutrophils, macrophages, B cells (sometimes forming follicles), T cells
• Goblet cell hyperplasia - excess mucus-secreting cells
• Smooth muscle hypertrophy in bronchiolar walls
• Peribronchial fibrosis - thickening of tissue around small airways

Side-by-Side Comparison

Key Exam Points

• Gross: Voluminous lungs, hidden heart, subpleural bullae at apex
• Micro: Enlarged alveoli + thin destroyed septa + floating/club-ended septal remnants + inflammatory infiltrates in airways
• The absence of fibrosis microscopically is what separates emphysema from other destructive lung conditions
• Bullae >1 cm rupturing into the pleural space = spontaneous pneumothorax (classic in young adults with paraseptal emphysema)

Step-by-Step Formation

Step 1 - Alveolar Wall Destruction

• Elastase and ROS destroy the walls between adjacent alveoli
• Multiple small alveoli lose their separating septa and merge into one larger space
• This is called confluence - the merged space holds more air than any single alveolus

Step 2 - Ball-Valve / Check-Valve Effect

• The small airways feeding these enlarged spaces become partially obstructed (inflamed walls, mucus, loss of elastic support)
• Air can flow in during inspiration (airways are pulled open by negative pressure)
• But during expiration, the already-collapsing airway closes before all the air escapes
• Result: more air enters than leaves with each breath cycle - progressive air trapping

Step 3 - Progressive Pressure Build-Up

• With each breath, a little more air accumulates in the trapped space
• The pressure inside the merged airspace gradually exceeds the surrounding lung pressure
• The thin, weakened walls of the space stretch outward

Step 4 - Bleb or Bulla Forms

• The expanding air pocket pushes outward toward the pleural surface (path of least resistance)
• It dissects through the loose connective tissue just under the visceral pleura
• A bleb forms when this air pocket is small (<1 cm) - essentially a subpleural air bubble
• With continued air trapping and expansion, the bleb grows into a bulla (>1 cm)

Why the Subpleural Location?

• Central lung parenchyma is surrounded and reinforced by adjacent alveoli on all sides
• Peripheral alveoli near the pleura have no support on one side
• Air preferentially dissects into the subpleural plane
• This is why bullae are almost always found at the apex and along pleural surfaces

Why the Apex Specifically?

• Pleural pressure is most negative (most sub-atmospheric) at the apex due to gravity
• This means apical alveoli are already subjected to greater distending pressure at baseline
• Any air trapping amplifies this further at the apex
• Blood flow is also lowest at the apex, so inflammatory repair is poorest there

Blebs vs Bullae - The Distinction

Which Type of Emphysema Forms Bullae?

The Danger - Pneumothorax

• Air escapes into the pleural space (which is normally a potential space under negative pressure)
• The negative pressure of the pleural space is lost
• The lung collapses on that side
• This is spontaneous pneumothorax - the classic complication of bullous/paraseptal emphysema, typically in tall, thin young men with apical bullae